Literature DB >> 18569772

Early detection and intervention of psychosis. A review.

Raimo K R Salokangas1, Thomas H McGlashan.   

Abstract

The vulnerability and hybrid models for the onset of psychosis are presented. Familial liability, perinatal and developmental factors, and decreased cognitive performance associate with psychosis in adolescence and young adulthood. Genetic predisposition connected with behavioural deviances and/or mental symptoms associate with psychotic development so strongly that monitoring and intervention are indicated. Especially, in families where one or both parents or other family members are severely mentally ill, early family-centred assessments and interventions is needed. Together with familial psychosis, deficits in adolescent and young adult social development indicate thorough assessment, intensive monitoring and often also preventive interventions. During the prodromal phase of psychosis, patients often display unspecific symptoms, such as anxiety and depression, personality disorders, abuse of alcohol or drugs. Social decline, possibly associated with neurocognitive deficits, frequently occurs in the prodromal phase or in the early course of schizophrenia. Among help-seeking patients, occurrence of the Basic Symptoms represent the early initial prodromal state, while the late initial prodome state includes attenuated psychotic symptoms, brief limited intermittent psychotic symptoms, and a first degree relative with psychotic disorder, or a schizotypal personality disorder, together with decrease global functioning. These patients suffer also from other mental symptoms and functional decline, and are clearly in need of psychiatric assessment and treatment. Intervention trials have shown that patients suffering from prodromal syndromes can be successfully treated, and onset of psychosis prevented or delayed. However, more large-scale studies and clinical case descriptions of treatment of patients with sub-threshold psychotic symptoms are needed.

Entities:  

Mesh:

Year:  2008        PMID: 18569772     DOI: 10.1080/08039480801984008

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  18 in total

1.  Poor school performance in offspring of patients with schizophrenia: what are the mechanisms?

Authors:  J Jundong; R Kuja-Halkola; C Hultman; N Långström; B M D'Onofrio; Paul Lichtenstein
Journal:  Psychol Med       Date:  2011-07-07       Impact factor: 7.723

2.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

Authors:  Yael Piontkewitz; Michal Arad; Ina Weiner
Journal:  Schizophr Bull       Date:  2010-05-03       Impact factor: 9.306

3.  Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.

Authors:  Masakuni Horiguchi; Kayleen E Hannaway; Adesewa E Adelekun; Karu Jayathilake; Herbert Y Meltzer
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

4.  Social skill and social cognition in adolescents at genetic risk for psychosis.

Authors:  Clare M Gibson; David L Penn; Mitchell J Prinstein; Diana O Perkins; Aysenil Belger
Journal:  Schizophr Res       Date:  2010-05-31       Impact factor: 4.939

5.  Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome.

Authors:  Kathryn Cullen; Angela Guimaraes; Jeffrey Wozniak; Afshan Anjum; S Charles Schulz; Tonya White
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

Review 6.  Treatment implications of the schizophrenia prodrome.

Authors:  Tejal Kaur; Kristin S Cadenhead
Journal:  Curr Top Behav Neurosci       Date:  2010

7.  Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.

Authors:  Nikolaos Koutsouleris; Eva M Meisenzahl; Christos Davatzikos; Ronald Bottlender; Thomas Frodl; Johanna Scheuerecker; Gisela Schmitt; Thomas Zetzsche; Petra Decker; Maximilian Reiser; Hans-Jürgen Möller; Christian Gaser
Journal:  Arch Gen Psychiatry       Date:  2009-07

8.  Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up.

Authors:  Raimo K R Salokangas; Dorien H Nieman; Markus Heinimaa; Tanja Svirskis; Sinikka Luutonen; Tiina From; Heinrich Graf von Reventlow; Georg Juckel; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Frauke Schultze-Lutter; Joachim Klosterkötter; Stephan Ruhrmann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-15       Impact factor: 4.328

9.  Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis.

Authors:  Diana Wotruba; Lars Michels; Roman Buechler; Sibylle Metzler; Anastasia Theodoridou; Miriam Gerstenberg; Susanne Walitza; Spyros Kollias; Wulf Rössler; Karsten Heekeren
Journal:  Schizophr Bull       Date:  2013-11-16       Impact factor: 9.306

10.  Packages of care for schizophrenia in low- and middle-income countries.

Authors:  Mari Jair de Jesus; Denise Razzouk; Rangaswamy Thara; Julian Eaton; Graham Thornicroft
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.